Goldman Sachs
GLSI icon

Goldman Sachs’s Greenwich LifeSciences GLSI Stock Holding History

Goldman Sachs’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$923K Sell
39,329
-192
-0.5% -$4.67K ﹤0.01% 5280
2026
Q1 		$949K Buy
39,521
+17,976
+83% +$469K ﹤0.01% 5126
2025
Q4 		$453K Buy
21,545
+1,700
+9% +$17.9K ﹤0.01% 5652
2025
Q3 		$197K Buy
19,845
+3,347
+20% +$37.8K ﹤0.01% 5957
2025
Q2 		$150K Buy
+16,498
New +$157K ﹤0.01% 5738
2025
Q1 		– Sell
-15,070
Closed -$169K – 6198
2024
Q4 		$169K Buy
+15,070
New +$202K ﹤0.01% 5684
2024
Q2 		– Sell
-41,505
Closed -$828K – 5752
2024
Q1 		$828K Buy
+41,505
New +$512K ﹤0.01% 4461
2022
Q3 		– Sell
-12,322
Closed -$104K – 6377
2022
Q2 		$104K Buy
+12,322
New +$141K ﹤0.01% 5852

Other funds holding GLSI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Goldman Sachs's GLSI Position: Q2 2026 in Review

Goldman Sachs reduced its Greenwich LifeSciences (GLSI) stake by 0.49% in Q2 2026, selling an estimated $4.67K and leaving 39,329 shares worth $923K. The position accounts for ﹤0.01% of the portfolio, ranked #5280.

Goldman Sachs first reported a position in GLSI in Q2 2022 and has held it in 8 quarters since. The position peaked at $949K in Q1 2026. 57 funds tracked by Wall St. Rank hold GLSI as of Q2 2026.

  • Goldman Sachs held 39,329 shares of Greenwich LifeSciences worth $923K as of Q2 2026.
  • Goldman Sachs sold 192 Greenwich LifeSciences shares in Q2 2026, an estimated $4.67K.
  • Greenwich LifeSciences made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #5280 holding.
  • Goldman Sachs first reported a position in Greenwich LifeSciences in Q2 2022 and has held it in 8 quarters since.
  • Goldman Sachs's Greenwich LifeSciences position peaked at $949K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.